RayzeBio, Inc.
DelistedCIK 1825367fmd_0NGMGHV2HTNFHVJTDBBJWNQ56CManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2022 to Sep 30, 2023, 2 periods
Latest quarter · Q3 FY2023
Millions- Operating income
- (22)
- Net income
- (18)